Table 1 NAT10 staining and clinicopathological characteristics of 428 patients.
Variables | Total | NAT10 | χ2 value | p value | |
|---|---|---|---|---|---|
Low (%) | High (%) | ||||
All cases | 428 | 210 (49.0) | 218 (51.0) | ||
Gender | |||||
Male | 208 | 108 (51.9) | 100 (48.1) | 1.535 | 0.215 |
Female | 220 | 102 (46.3) | 118 (53.7) | ||
Age | |||||
≤42 | 204 | 106 (49.5) | 98 (17.4) | 1.308 | 0.253 |
>42 | 224 | 104 (46.4) | 120 (53.5) | ||
WHO grade | |||||
Benign (Ⅰ-Ⅱ) | 221 | 145 (65.6) | 76 (34.4) | 59.714 | <0.001 |
Malignant (Ⅲ-Ⅳ) | 207 | 65 (31.4) | 142 (68.6) | ||
Histological type | |||||
Glioblastoma | 25 | 15 (60.0) | 10 (40.0) | 7.879 | 0.163 |
Astrocytoma | 90 | 49 (54.4) | 41 (45.6) | ||
Oligodendroglioma | 15 | 6 (40) | 9 (60) | ||
Ependymoma | 4 | 4 (100) | 0 (0) | ||
Medulloblastoma | 14 | 6 (42.9) | 8 (57.1) | ||
Gliocytoma | 280 | 130 (46.4) | 150 (53.6) | ||
